High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-X(L) in chronic myeloid leukemia

por Lucas, C M, Milani, M, Butterworth, M, Carmell, N, Scott, L J, Clark, R E, Cohen, G M, Varadarajan, S
Publicado 2016